Research published in Aging Cell reveals that the enzyme Pck1 plays a critical role in maintaining metabolic health in adipose tissue, particularly in mitigating cellular senescence. Mice lacking Pck1 exhibited increased adipocyte senescence and metabolic dysfunction, such as insulin resistance, by 12 and 24 months of age, despite no significant differences in body weight. This deficiency was exacerbated by a high-fat diet, which further reduced Pck1 expression and led to greater inflammation and mitochondrial dysfunction in adipocytes.

The significance of these findings lies in the connection between Pck1 depletion and inflammaging, the chronic inflammation associated with aging. The study identified that Pck1-deficient adipocytes accumulated metabolites like fumarate and succinate, which are linked to the TCA cycle. The presence of these metabolites correlated with increased secretion of senescence-associated secretory phenotype (SASP) factors and signs of immune cell infiltration, indicating a heightened inflammatory state. Notably, the depletion of Pck1 resulted in mitochondrial dysfunction characterized by misshapen mitochondria and elevated reactive oxygen species (ROS), further implicating Pck1 in cellular metabolic health.

The takeaway from this research is the potential of Pck1 as a therapeutic target for addressing age-related metabolic disorders. By understanding the mechanisms by which Pck1 influences adipocyte senescence and inflammation, future interventions could be designed to enhance metabolic resilience in aging populations. This study underscores the need for further exploration of Pck1’s role across different tissues, which could reshape strategies in longevity research and therapeutic development aimed at improving healthspan.

Source: lifespan.io